These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 19166822)
1. The selective aryl hydrocarbon receptor modulator 6-methyl-1,3,8-trichlorodibenzofuran inhibits prostate tumor metastasis in TRAMP mice. Fritz WA; Lin TM; Safe S; Moore RW; Peterson RE Biochem Pharmacol; 2009 Apr; 77(7):1151-60. PubMed ID: 19166822 [TBL] [Abstract][Full Text] [Related]
2. The aryl hydrocarbon receptor (AhR) inhibits vanadate-induced vascular endothelial growth factor (VEGF) production in TRAMP prostates. Fritz WA; Lin TM; Peterson RE Carcinogenesis; 2008 May; 29(5):1077-82. PubMed ID: 18359762 [TBL] [Abstract][Full Text] [Related]
3. The aryl hydrocarbon receptor inhibits prostate carcinogenesis in TRAMP mice. Fritz WA; Lin TM; Cardiff RD; Peterson RE Carcinogenesis; 2007 Feb; 28(2):497-505. PubMed ID: 17052998 [TBL] [Abstract][Full Text] [Related]
4. Lack of antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin's (TCDDs) induction of cytochrome P4501A1 (CYP1A1) by the putative selective aryl hydrocarbon receptor modulator 6-alkyl-1,3,8-trichlorodibenzofuran (6-MCDF) in the mouse hepatoma cell line Hepa-1c1c7. Fretland AJ; Safe S; Hankinson O Chem Biol Interact; 2004 Nov; 150(2):161-70. PubMed ID: 15535986 [TBL] [Abstract][Full Text] [Related]
5. Interaction of the aryl hydrocarbon receptor ligand 6-methyl-1,3,8-trichlorodibenzofuran with estrogen receptor alpha. Pearce ST; Liu H; Radhakrishnan I; Abdelrahim M; Safe S; Jordan VC Cancer Res; 2004 Apr; 64(8):2889-97. PubMed ID: 15087408 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor growth by aryl hydrocarbon receptor agonists. McDougal A; Wilson C; Safe S Cancer Lett; 1997 Nov; 120(1):53-63. PubMed ID: 9570386 [TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor-mediated inhibition of LNCaP prostate cancer cell growth and hormone-induced transactivation. Morrow D; Qin C; Smith R; Safe S J Steroid Biochem Mol Biol; 2004 Jan; 88(1):27-36. PubMed ID: 15026081 [TBL] [Abstract][Full Text] [Related]
8. 2,3,7,8-Tetrachlorodibenzo-p-dioxin has both pro-carcinogenic and anti-carcinogenic effects on neuroendocrine prostate carcinoma formation in TRAMP mice. Moore RW; Fritz WA; Schneider AJ; Lin TM; Branam AM; Safe S; Peterson RE Toxicol Appl Pharmacol; 2016 Aug; 305():242-249. PubMed ID: 27151233 [TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon receptor as a drug target in advanced prostate cancer therapy - obstacles and perspectives. Procházková J; Kahounová Z; Vondráček J; Souček K Transcription; 2024 Mar; ():1-20. PubMed ID: 38547312 [TBL] [Abstract][Full Text] [Related]
10. Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells. Zhang S; Kim K; Jin UH; Pfent C; Cao H; Amendt B; Liu X; Wilson-Robles H; Safe S Mol Cancer Ther; 2012 Jan; 11(1):108-18. PubMed ID: 22034498 [TBL] [Abstract][Full Text] [Related]
11. Partial antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated induction of aryl hydrocarbon hydroxylase by 6-methyl-1,3,8-trichlorodibenzofuran: mechanistic studies. Harris M; Zacharewski T; Astroff B; Safe S Mol Pharmacol; 1989 May; 35(5):729-35. PubMed ID: 2542761 [TBL] [Abstract][Full Text] [Related]
12. 6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist in C57BL/6 mice. Bannister R; Biegel L; Davis D; Astroff B; Safe S Toxicology; 1989 Feb; 54(2):139-50. PubMed ID: 2922766 [TBL] [Abstract][Full Text] [Related]
13. Aromatic hydrocarbon receptor inhibits lysophosphatidic acid-induced vascular endothelial growth factor-A expression in PC-3 prostate cancer cells. Wu PY; Lin YC; Lan SY; Huang YL; Lee H Biochem Biophys Res Commun; 2013 Aug; 437(3):440-5. PubMed ID: 23831623 [TBL] [Abstract][Full Text] [Related]
14. Non-dioxin-like AhR ligands in a mouse peanut allergy model. Schulz VJ; Smit JJ; Huijgen V; Bol-Schoenmakers M; van Roest M; Kruijssen LJ; Fiechter D; Hassing I; Bleumink R; Safe S; van Duursen MB; van den Berg M; Pieters RH Toxicol Sci; 2012 Jul; 128(1):92-102. PubMed ID: 22491429 [TBL] [Abstract][Full Text] [Related]
15. The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy. Zhang S; Lei P; Liu X; Li X; Walker K; Kotha L; Rowlands C; Safe S Endocr Relat Cancer; 2009 Sep; 16(3):835-44. PubMed ID: 19447902 [TBL] [Abstract][Full Text] [Related]
16. Comparative antiestrogenic activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 6-methyl-1,3,8-trichlorodibenzofuran in the female rat. Astroff B; Safe S Toxicol Appl Pharmacol; 1988 Sep; 95(3):435-43. PubMed ID: 2847362 [TBL] [Abstract][Full Text] [Related]
17. Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator. McDougal A; Wormke M; Calvin J; Safe S Cancer Res; 2001 May; 61(10):3902-7. PubMed ID: 11358803 [TBL] [Abstract][Full Text] [Related]
18. 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities. Astroff B; Zacharewski T; Safe S; Arlotto MP; Parkinson A; Thomas P; Levin W Mol Pharmacol; 1988 Feb; 33(2):231-6. PubMed ID: 2828916 [TBL] [Abstract][Full Text] [Related]
19. 6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as an antiestrogen in human and rodent cancer cell lines: evidence for the role of the Ah receptor. Zacharewski T; Harris M; Biegel L; Morrison V; Merchant M; Safe S Toxicol Appl Pharmacol; 1992 Apr; 113(2):311-8. PubMed ID: 1313996 [TBL] [Abstract][Full Text] [Related]
20. A role for the aryl hydrocarbon receptor in regulation of ischemia-induced angiogenesis. Ichihara S; Yamada Y; Ichihara G; Nakajima T; Li P; Kondo T; Gonzalez FJ; Murohara T Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1297-304. PubMed ID: 17413038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]